ERFSF:OTO-Eurofins Scientific Nante (USD)

COMMON STOCK | Diagnostics & Research | OTC Pink

Last Closing

USD 48.433

Change

+0.81 (+1.71)%

Market Cap

USD 7.27B

Volume

3.29K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Eurofins Scientific SE is engaged providing food, environment and pharmaceutical products testing. It also provides agroscience, genomics, discovery pharmacology and central laboratory services; and also specialty clinical diagnostic testing.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-03 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
TMO Thermo Fisher Scientific Inc

+4.49 (+0.84%)

USD 204.45B
DHR Danaher Corporation

-0.75 (-0.31%)

USD 188.85B
IQV IQVIA Holdings Inc

+1.29 (+0.62%)

USD 37.99B
A Agilent Technologies Inc

+0.24 (+0.19%)

USD 36.87B
MTD Mettler-Toledo International I..

-8.02 (-0.59%)

USD 28.92B
LH Laboratory Corporation of Amer..

+0.72 (+0.35%)

USD 17.57B
WAT Waters Corporation

-1.29 (-0.45%)

USD 17.05B
DGX Quest Diagnostics Incorporated

-0.45 (-0.32%)

USD 15.40B
RVTY Revvity Inc.

+1.00 (+0.98%)

USD 12.87B
CRL Charles River Laboratories

-1.76 (-0.87%)

USD 10.90B

ETFs Containing ERFSF

MXU:CA Mackenzie Maximum Diversi.. 0.00 % 0.62 %

+0.06 (+0%)

CAD 0.05B
IDLB 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (OTC Pink)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -24.69% 7% C- 8% B-
Dividend Return 0.84% 75% C 24% F
Total Return -23.85% 7% C- 7% C-
Trailing 12 Months  
Capital Gain -22.88% 21% F 11% F
Dividend Return 0.86% 57% F 10% F
Total Return -22.02% 21% F 10% F
Trailing 5 Years  
Capital Gain 964.39% 100% F 99% N/A
Dividend Return 78.79% 100% F 99% N/A
Total Return 1,043.18% 100% F 99% N/A
Average Annual (5 Year Horizon)  
Capital Gain 396.43% 94% A 93% A
Dividend Return 398.29% 94% A 92% A
Total Return 1.86% 64% D 47% F
Risk Return Profile  
Volatility (Standard Deviation) 709.80% 13% F 12% F
Risk Adjusted Return 56.11% 100% F 89% A-
Market Capitalization 7.27B 29% F 84% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.